Harvey Investment Co. LLC boosted its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 0.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 190,561 shares of the company’s stock after buying an additional 499 shares during the period. Dentsply International comprises about 2.6% of Harvey Investment Co. LLC’s investment portfolio, making the stock its 15th largest position. Harvey Investment Co. LLC owned 0.08% of Dentsply International worth $11,822,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Checchi Capital Advisers LLC raised its position in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock worth $125,000 after buying an additional 41 shares during the last quarter. Carnick & Kubik LLC purchased a new position in Dentsply International during the first quarter worth about $201,000. Cacti Asset Management LLC purchased a new position in Dentsply International during the second quarter worth about $203,000. Stratos Wealth Partners LTD. purchased a new position in Dentsply International during the first quarter worth about $208,000. Finally, Trust Co. of Vermont raised its position in Dentsply International by 7.3% in the second quarter. Trust Co. of Vermont now owns 3,669 shares of the company’s stock worth $227,000 after buying an additional 250 shares during the last quarter. 94.58% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Dentsply International (NASDAQ:XRAY)

Dentsply International Inc. (NASDAQ:XRAY) traded up 0.05% during midday trading on Wednesday, hitting $58.93. 909,588 shares of the stock were exchanged. Dentsply International Inc. has a one year low of $52.73 and a one year high of $65.83. The company has a 50 day moving average price of $60.15 and a 200 day moving average price of $61.43.

Dentsply International (NASDAQ:XRAY) last posted its earnings results on Friday, August 5th. The company reported $0.76 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.70 by $0.06. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the firm earned $0.73 EPS. The firm’s quarterly revenue was up 46.4% compared to the same quarter last year. On average, equities research analysts predict that Dentsply International Inc. will post $2.76 EPS for the current fiscal year.

The company also recently announced a dividend, which will be paid on Friday, October 14th. Stockholders of record on Friday, September 30th will be issued a $0.0775 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s payout ratio is 14.49%.

A number of research firms have issued reports on XRAY. Piper Jaffray Cos. assumed coverage on shares of Dentsply International in a research note on Monday, June 13th. They set an “overweight” rating and a $70.00 target price for the company. Credit Suisse Group AG restated a “buy” rating on shares of Dentsply International in a research report on Sunday, June 26th. Robert W. Baird restated an “outperform” rating and set a $67.00 price target (down from $69.00) on shares of Dentsply International in a research report on Tuesday. Bank of America Corp. assumed coverage on shares of Dentsply International in a research report on Monday, September 12th. They set a “buy” rating and a $70.00 price target on the stock. Finally, Barrington Research downgraded shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $66.91.

In other news, SVP Maureen J. Macinnis sold 17,650 shares of the company’s stock in a transaction dated Tuesday, August 23rd. The shares were sold at an average price of $60.61, for a total value of $1,069,766.50. Following the sale, the senior vice president now owns 19,630 shares of the company’s stock, valued at approximately $1,189,774.30. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Rainer Berthan sold 5,000 shares of the company’s stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the sale, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.